1887

Journal of General Virology header logo

Volume 95, Issue 8

Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator Free

Abstract

Persistent infection of hepatitis C virus (HCV) can lead to liver cirrhosis and hepatocellular carcinoma, which are currently diagnosed by invasive liver biopsy. Approximately 15–20 % of cases of chronic liver diseases in India are caused by HCV infection. In North India, genotype 3 is predominant, whereas genotype 1 is predominant in southern parts of India. The aim of this study was to identify differentially regulated serum proteins in HCV-infected Indian patients (genotypes 1 and 3) using a two-dimensional electrophoresis approach. We identified eight differentially expressed proteins by MS. Expression levels of one of the highly upregulated proteins, retinol-binding protein 4 (RBP4), was validated by ELISA and Western blotting in two independent cohorts. We also confirmed our observation in the JFH1 infectious cell culture system. Interestingly, the HCV core protein enhanced RBP4 levels and partial knockdown of RBP4 had a positive impact on HCV replication, suggesting a possible role for this cellular protein in regulating HCV infection. Analysis of RBP4-interacting partners using a bioinformatic approach revealed novel insights into the possible involvement of RBP4 in HCV-induced pathogenesis. Taken together, this study provided information on the proteome profile of the HCV-infected Indian population, and revealed a link between HCV infection, RBP4 and insulin resistance.

  • Received:
  • Accepted:
  • Published Online:
© 2014 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.062430-0
2014-08-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/8/1654.html?itemId=/content/journal/jgv/10.1099/vir.0.062430-0&mimeType=html&fmt=ahah

References

  1. Albuquerque L. M., Trugilho M. R., Chapeaurouge A., Jurgilas P. B., Bozza P. T., Bozza F. A., Perales J., Neves-Ferreira A. G. 2009; Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res 8:5431–5441 [View Article][PubMed]
     [Google Scholar]
  2. Alkhouri N., Lopez R., Berk M., Feldstein A. E. 2009; Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol 43:985–989 [View Article][PubMed]
     [Google Scholar]
  3. Amarapurkar D. N., Patel N. D. 2008; Increased prevalence of type II diabetes mellitus in hepatitis C virus infection in western India. Trop Gastroenterol 29:148–152[PubMed]
     [Google Scholar]
  4. Benali-Furet N. L., Chami M., Houel L., De Giorgi F., Vernejoul F., Lagorce D., Buscail L., Bartenschlager R., Ichas F.other authors 2005; Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene 24:4921–4933 [View Article][PubMed]
     [Google Scholar]
  5. Biddinger S. B., Kahn C. R. 2006; From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123–158 [View Article][PubMed]
     [Google Scholar]
  6. Blum H., Beier H., Gross J. H. 1987; Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8:93–99 [View Article]
     [Google Scholar]
  7. Broch M., Vendrell J., Ricart W., Richart C., Fernández-Real J. M. 2007; Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 30:1802–1806 [View Article][PubMed]
     [Google Scholar]
  8. Chen J. H., Chang Y. W., Yao C. W., Chiueh T. S., Huang S. C., Chien K. Y., Chen A., Chang F. Y., Wong C. H., Chen Y. J. 2004; Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A 101:17039–17044 [View Article][PubMed]
     [Google Scholar]
  9. Chen Y. Y., Lin S. Y., Yeh Y. Y., Hsiao H. H., Wu C. Y., Chen S. T., Wang A. H. 2005; A modified protein precipitation procedure for efficient removal of albumin from serum. Electrophoresis 26:2117–2127 [View Article][PubMed]
     [Google Scholar]
  10. Cheung K. J., Tilleman K., Deforce D., Colle I., Van Vlierberghe H. 2009; The HCV serum proteome: a search for fibrosis protein markers. J Viral Hepat 16:418–429 [View Article][PubMed]
     [Google Scholar]
  11. Chowdhury A., Santra A., Chaudhuri S., Dhali G. K., Chaudhuri S., Maity S. G., Naik T. N., Bhattacharya S. K., Mazumder D. N. 2003; Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 37:802–809 [View Article][PubMed]
     [Google Scholar]
  12. El-Zayadi A., Anis M. 2012; Hepatitis C virus induced insulin resistance impairs response to antiviral therapy. World J Gastroenterol 183:212–224 [View Article]
     [Google Scholar]
  13. Frese M., Barth K., Kaul A., Lohmann V., Schwärzle V., Bartenschlager R. 2003; Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. J Gen Virol 84:1253–1259 [View Article][PubMed]
     [Google Scholar]
  14. Gangadharan B., Antrobus R., Dwek R. A., Zitzmann N. 2007; Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 53:1792–1799 [View Article][PubMed]
     [Google Scholar]
  15. Gangadharan B., Bapat M., Rossa J., Antrobus R., Chittenden D., Kampa B., Barnes E., Klenerman P., Dwek R. A., Zitzmann N. 2012; Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. PLoS ONE 7:e39603 [View Article][PubMed]
     [Google Scholar]
  16. Higgs M. R., Lerat H., Pawlotsky J. M. 2012; Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events. Oncogene 32:4683–4693 [View Article][PubMed]
     [Google Scholar]
  17. Hissar S. S., Goyal A., Kumar M., Pandey C., Suneetha P. V., Sood A., Midha V., Sakhuja P., Malhotra V., Sarin S. K. 2006; Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 78:452–458 [View Article][PubMed]
     [Google Scholar]
  18. Huang J. F., Dai C. Y., Yu M. L., Shin S. J., Hsieh M. Y., Huang C. F., Lee L. P., Lin K. D., Lin Z. Y.other authors 2009; Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C. J Hepatol 50:471–478 [View Article][PubMed]
     [Google Scholar]
  19. Janke J., Engeli S., Boschmann M., Adams F., Böhnke J., Luft F. C., Sharma A. M., Jordan J. 2006; Retinol-binding protein 4 in human obesity. Diabetes 55:2805–2810 [View Article][PubMed]
     [Google Scholar]
  20. Kotnik P., Fischer-Posovszky P., Wabitsch M. 2011; RBP4: a controversial adipokine. Eur J Endocrinol 165:703–711 [View Article][PubMed]
     [Google Scholar]
  21. Lavanchy D. 2011; Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17:107–115 [View Article][PubMed]
     [Google Scholar]
  22. Mangia A., Ripoli M. 2013; Insulin resistance, steatosis and hepatitis C virus. Hepatol Int 7:Suppl 2782–789 [View Article][PubMed]
     [Google Scholar]
  23. Okuda M., Li K., Beard M. R., Showalter L. A., Scholle F., Lemon S. M., Weinman S. A. 2002; Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366–375 [View Article][PubMed]
     [Google Scholar]
  24. Panigrahi A. K., Roca J., Acharya S. K., Jameel S., Panda S. K. 1996; Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 48:191–198 [View Article][PubMed]
     [Google Scholar]
  25. Petta S., Cammà C., Di Marco V., Alessi N., Barbaria F., Cabibi D., Caldarella R., Ciminnisi S., Licata A.other authors 2008; Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology 48:28–37 [View Article][PubMed]
     [Google Scholar]
  26. Qin S., Zhou Y., Lok A. S., Tsodikov A., Yan X., Gray L., Yuan M., Moritz R. L., Galas D.other authors 2012; SRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients. Proteomics 12:1244–1252 [View Article][PubMed]
     [Google Scholar]
  27. Raghuraman S., Shaji R. V., Sridharan G., Radhakrishnan S., Chandy G., Ramakrishna B. S., Abraham P. 2003; Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 26:61–69 [View Article][PubMed]
     [Google Scholar]
  28. Ramia S., Eid-Fares J. 2006; Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 10:272–277 [View Article][PubMed]
     [Google Scholar]
  29. Rukmangadachar L. A., Kataria J., Hariprasad G., Samantaray J. C., Srinivasan A. 2011; Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin Proteomics 8:4–8 [View Article][PubMed]
     [Google Scholar]
  30. Shea J. L., Loredo-Osti J. C., Sun G. 2010; Association of RBP4 gene variants and serum HDL cholesterol levels in the Newfoundland population. Obesity (Silver Spring) 18:1393–1397 [View Article][PubMed]
     [Google Scholar]
  31. Shi S. T., Polyak S. J., Tu H., Taylor D. R., Gretch D. R., Lai M. M. C. 2002; Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292:198–210 [View Article][PubMed]
     [Google Scholar]
  32. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. 1993; Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399 [View Article][PubMed]
     [Google Scholar]
  33. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., Halfon P., Inchauspé G., Kuiken C.other authors 2005; Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962–973 [View Article][PubMed]
     [Google Scholar]
  34. Simula M. P., Notarpietro A., Toffoli G., De Re V. 2012; 2-D gel electrophoresis: constructing 2D-gel proteome reference maps. Methods Mol Biol 815:163–173 [View Article][PubMed]
     [Google Scholar]
  35. Soriano V., Peters M. G., Zeuzem S. 2009; New therapies for hepatitis C virus infection. Clin Infect Dis 48:313–320 [View Article][PubMed]
     [Google Scholar]
  36. Srivastava R., Ray S., Vaibhav V., Gollapalli K., Jhaveri T., Taur S., Dhali S., Gogtay N., Thatte U.other authors 2012; Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics 76:56–68 [View Article][PubMed]
     [Google Scholar]
  37. Valliammai T., Thyagarajan S. P., Zuckerman A. J., Harrison T. J. 1995; Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 76:711–716 [View Article][PubMed]
     [Google Scholar]
  38. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H. G.other authors 2005; Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791–796 [View Article][PubMed]
     [Google Scholar]
  39. White I. R., Patel K., Symonds W. T., Dev A., Griffin P., Tsokanas N., Skehel M., Liu C., Zekry A.other authors 2007; Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med 5:33–36 [View Article][PubMed]
     [Google Scholar]
  40. Xia M., Liu Y., Guo H., Wang D., Wang Y., Ling W. 2013; Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway. Hepatology 58:564–575 [View Article][PubMed]
     [Google Scholar]
  41. Yagmur E., Weiskirchen R., Gressner A. M., Trautwein C., Tacke F. 2007; Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30:1168–1172 [View Article][PubMed]
     [Google Scholar]
  42. Yang Q., Graham T. E., Mody N., Preitner F., Peroni O. D., Zabolotny J. M., Kotani K., Quadro L., Kahn B. B. 2005; Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356–362 [View Article][PubMed]
     [Google Scholar]
  43. Yao-Borengasser A., Varma V., Bodles A. M., Rasouli N., Phanavanh B., Lee M. J., Starks T., Kern L. M., Spencer H. J. IIIother authors 2007; Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92:2590–2597 [View Article][PubMed]
     [Google Scholar]
  44. Yoon S. Y., Kim J. M., Oh J. H., Jeon Y. J., Lee D. S., Kim J. H., Choi J. Y., Ahn B. M., Kim S.other authors 2006; Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol 29:315–327[PubMed]
     [Google Scholar]
  45. Zarkesh-Esfahani S. H., Kardi M. T., Edalati M. 2010; Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study. Virol J 7:69–75 [View Article][PubMed]
     [Google Scholar]
  46. Zelcer N., Tontonoz P. 2006; Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.062430-0
Loading
Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator
J. Gen. Virol. 95, 1654 (2014); https://doi.org/10.1099/vir.0.062430-0
/content/journal/jgv/10.1099/vir.0.062430-0
/content/journal/jgv/10.1099/vir.0.062430-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error